These effects on T cells may be related to direct activation of signaling pathways, as treatment of tumor bearing mice with Vel resulted in upregulation in activated CD8+ T cells of Notch pathway components and enhanced IFN-γ secretion and expression of the effector molecules perforin and granzyme B [35]. The gene discussed is GZMB; the disease is neoplasm.